What Does 21 CFR Part 11 Require?
Title 21, Code of Federal Regulations, Part 11 (21 CFR Part 11) establishes the criteria under which the FDA considers electronic records and electronic signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. Any organization conducting FDA-regulated clinical trials must demonstrate compliance with Part 11 whenever electronic systems are used to create, modify, maintain, archive, retrieve, or transmit clinical data.
The regulation addresses four core pillars: audit trails that capture every change to electronic records, electronic signatures that are legally binding and attributable to a single individual, access controls that restrict system use to authorized personnel, and system validation that proves the software performs as intended under all operating conditions. Failure to comply can result in FDA Form 483 observations, warning letters, consent decree agreements, and the rejection of clinical trial data during regulatory submissions.
How AccuraTrials Addresses Every Part 11 Requirement
AccuraTrials does not treat compliance as an afterthought or a documentation exercise. Each Part 11 requirement is implemented as an architectural feature — enforced by code, not by policy alone.
Immutable Audit Trails
Every data modification is recorded with a timestamp, the authenticated user identity, the prior value, the new value, and a mandatory reason for change. Audit trail records are append-only and cannot be edited or deleted by any user, including system administrators. Trails span the entire data lifecycle — from initial entry through queries, corrections, locks, and e-signatures.
Electronic Signatures with Re-Authentication
E-signatures in AccuraTrials require the signer to re-enter their full credentials (username and password) along with a documented reason at the moment of signing. Each signature is cryptographically bound to the record it signs, making it impossible to apply a signature retroactively or transfer it to a different record. Signatures comply with both 21 CFR Part 11 Subpart C and ICH E6(R2) requirements.
Role-Based Access Controls
AccuraTrials enforces 28 granular permission levels across the system. Each user is assigned roles scoped to specific studies and sites, ensuring that a data manager at Site A cannot view or modify records at Site B. Permission checks occur at every API request — not just in the user interface — preventing unauthorized access regardless of how the request originates.
Session Management & Device Fingerprinting
Configurable idle timeouts automatically lock sessions after a defined period of inactivity, requiring re-authentication before the user can continue. Device fingerprinting detects when a session token is used from an unrecognized device or browser. Single-session enforcement prevents credential sharing by invalidating previous sessions when a new login occurs.
Data Locking & Freezing Workflows
Once clinical data is locked at the form, visit, or subject level, it becomes immutable. No user — regardless of role — can modify locked records without first executing a formal unlock workflow that itself is logged in the audit trail. Data freezing provides an intermediate state for review periods, where data is visible but not editable, supporting database lock activities before final submission.
Automated Part 11 Compliance Testing
AccuraTrials includes a built-in compliance test suite that continuously validates Part 11 controls. The suite verifies audit trail completeness, signature binding integrity, access control enforcement, session timeout behavior, and data lock immutability. These automated tests provide documented evidence of ongoing compliance — exactly what FDA inspectors look for during Bioresearch Monitoring (BIMO) inspections.
How AI Audit Trails Work
AccuraTrials integrates an AI copilot that assists clinical teams with data entry, validation rule creation, query resolution, and protocol interpretation. In a regulated environment, AI-generated suggestions carry the same compliance burden as human actions — they must be traceable, attributable, and auditable.
Every interaction with the AI copilot is recorded in the same immutable audit trail used for all other system actions. This includes the prompt submitted by the user, the AI-generated suggestion, whether the user accepted or rejected the suggestion, any modifications made to the suggestion before applying it, and the final value written to the database. If an FDA inspector asks "where did this value come from?", the audit trail provides a complete chain of custody — from the AI suggestion through human review to the final recorded data point.
This approach ensures that AI accelerates clinical workflows without introducing regulatory risk. The human remains the decision-maker; the AI is a documented tool whose contributions are fully transparent.
Part 11 Requirements vs. AccuraTrials Implementation
| 21 CFR Part 11 Requirement | How AccuraTrials Implements It |
|---|---|
| Computer-generated, time-stamped audit trails (§11.10(e)) | Append-only audit log capturing timestamp, user, prior value, new value, and reason for every record change |
| Electronic signatures linked to records (§11.70) | Cryptographic binding of e-signature to the exact record version, with credential re-authentication at signing |
| Authority checks / access controls (§11.10(d)) | 28-level role-based permissions scoped per study and site, enforced at the API layer |
| Unique user identification (§11.100) | Unique username/password combinations with device fingerprinting and single-session enforcement |
| System validation (§11.10(a)) | Automated compliance test suite with documented validation evidence generated on every release |
| Protection of records for accuracy and availability (§11.10(c)) | AES-256 encrypted backups with automated key rotation, point-in-time recovery, and geographic redundancy |
| Operational system checks (§11.10(f)) | Field-level validation rules, cross-form consistency checks, and real-time data integrity monitoring |
Frequently Asked Questions About 21 CFR Part 11 Compliance
Does AccuraTrials meet 21 CFR Part 11 requirements out of the box?
Yes. AccuraTrials is architecturally designed for Part 11 compliance. Audit trails, electronic signatures, access controls, and session management are built into the platform core — not added as optional modules. Every new deployment includes these capabilities by default, and the automated compliance test suite verifies them continuously.
How does AccuraTrials handle audit trail integrity?
Audit trail records are stored in an append-only data structure. No user, including system administrators, can edit or delete audit entries. Each entry includes a server-generated timestamp, the authenticated user identity, the field changed, the prior value, the new value, and a mandatory reason for change. This provides the complete, unbroken record trail that FDA inspectors require under §11.10(e).
Are electronic signatures in AccuraTrials legally binding under FDA regulations?
Yes. Electronic signatures in AccuraTrials comply with 21 CFR Part 11 Subpart C. Each signature requires the signer to re-authenticate with their unique credentials and provide a documented reason for signing. The signature is cryptographically bound to the specific record version, ensuring it cannot be reused, transferred, or applied retroactively.
What happens if our study is audited by the FDA?
AccuraTrials generates audit-ready reports that document every data change, signature event, access control decision, and system validation result. During a BIMO inspection, you can export a complete audit trail for any subject, visit, or form in a format that inspectors can review independently. The automated compliance test suite also provides documented evidence that the system was validated and operating correctly throughout the study.
Does AccuraTrials support closed-system controls as defined in Part 11?
Yes. AccuraTrials implements all closed-system controls specified in §11.10, including system access limited to authorized individuals, operational system checks for data accuracy, device and session controls to verify user identity, and documented procedures for system operation and maintenance. For organizations that require open-system controls (§11.30), document-level encryption is also available.
Ready to Achieve Part 11 Compliance Without the Overhead?
AccuraTrials gives your clinical team a fully compliant EDC platform — audit trails, e-signatures, access controls, and validation documentation included from day one. No bolt-on modules, no compliance consultants required.
Schedule a Compliance DemoLearn more: Regulatory Compliance Overview · EDC Software Platform · Product Features